tiprankstipranks
BB Biotech AG (GB:0JYO)
LSE:0JYO
Holding GB:0JYO?
Track your performance easily

BB Biotech (0JYO) Financial Statements

3 Followers

BB Biotech Financial Overview

BB Biotech's market cap is currently ―. The company's EPS TTM is CHF2.285; its P/E ratio is 15.49; and it has a dividend yield of 5.65%. BB Biotech is scheduled to report earnings on February 21, 2025, and the estimated EPS forecast is CHF―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Mar 21Jun 17Mar 17
Income Statement-
Total RevenueCHF -222.52MCHF -298.02MCHF 223.06MCHF 113.08MCHF 376.79M
Ebit-----
Ebitda-----
Net Income Common StockholdersCHF -233.06MCHF -299.86MCHF 220.95MCHF 103.39MCHF 375.00M
Balance Sheet-
Total AssetsCHF 2.85BCHF 3.12B-CHF 3.36BCHF 3.53B
Total DebtCHF 326.00MCHF 355.00MCHF 0.00CHF 0.00CHF 310.00M
Net DebtCHF -2.52BCHF -2.76BCHF 0.00CHF -3.33BCHF -3.22B
Total LiabilitiesCHF 334.46MCHF 359.64M-CHF 30.12MCHF 313.67M
Stockholders EquityCHF 2.52BCHF 2.76B-CHF 3.33BCHF 3.22B
Cash Flow-
Free Cash FlowCHF 37.34MCHF 221.08MCHF -100.02MCHF 319.69MCHF 52.41M
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash FlowCHF -37.32MCHF -223.00MCHF 96.92MCHF -302.45MCHF -56.19M
Currency in CHF

BB Biotech Earnings and Revenue History

BB Biotech Debt to Assets

BB Biotech Cash Flow

BB Biotech Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis